← Back to home

RALOX-HAIC（HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH RALTITREXED AND OXALIPLATIN

Clinical trials for RALOX-HAIC（HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH RALTITREXED AND OXALIPLATIN explained in plain language.

Never miss a new study

Get alerted when new RALOX-HAIC（HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH RALTITREXED AND OXALIPLATIN trials appear

Sign up with your email to follow new studies for RALOX-HAIC（HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH RALTITREXED AND OXALIPLATIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Triple-Threat attack on tough liver cancer

Disease control Recruiting now

This study is testing a new three-part treatment for people with advanced liver cancer that has spread into a major vein in the liver. The treatment combines immunotherapy, a targeted drug, and chemotherapy delivered directly to the liver. The main goal is to see if this combinat…

Matched conditions: RALOX-HAIC（HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH RALTITREXED AND OXALIPLATIN

Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

RALOX-HAIC（HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH RALTITREXED AND OXALIPLATIN

Get alerted when new RALOX-HAIC（HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH RALTITREXED AND OXALIPLATIN trials appear

Triple-Threat attack on tough liver cancer